Evaluation of the area under the curve of enteric-coated mycophenolate sodium using a limited sampling strategy in Chinese kidney transplant recipients

被引:4
作者
Huang, Hongfeng [1 ]
Yao, Xi [1 ]
Wu, Jianyong [1 ]
Peng, Wenhan [1 ]
Chen, Jianghua [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Kidney Dis Ctr, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China
关键词
limited sampling strategy; MPA AUC; mycophenolate sodium; cyclosporine; pharmacokinetics; renal transplantation; CONCENTRATION-TIME CURVE; ACID EXPOSURE; RENAL-TRANSPLANTATION; EMIT IMMUNOASSAY; MOFETIL; TACROLIMUS; PHARMACOKINETICS; POSTTRANSPLANT; CYCLOSPORINE; METAANALYSIS;
D O I
10.5414/CP202583
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims: To investigate the area under the curve (AUC) of mycophenolic acid (MPA) in adult Chinese renal allograft recipients receiving concomitant enteric-coated mycophenolate sodium (EC-MPS) and cyclosporine (CsA) during the early post-transplant phase and to develop optimal model equations for estimation of the MPA area under the plasma concentration-time curve from 0 to 12 hours (AUC(0-12h)) using a limited-sampling strategy (LSS). Methods: The present study enrolled 24 Chinese renal recipients treated with EC-MPS, CsA, and corticosteroid, from whom 24 serial blood samples were collected over 12 hours. MPA concentration was evaluated with enzyme multiplied immunoassay technique (EMIT). LSS was developed by multiple stepwise regression analysis using a two-group method (test group, n = 12; and validation group, n = 12). Results: The MPA predose concentration had a poor correlation with MPA AUC(0-12h), and the best equations obtained from the test group were the following: 25.73 + 0.59 x C1.5 + 0.79 x C2 + 2.03 x C4 (for three time points, r(2) = 0.761) and 22.13 + 1.7 x C0.5 + 0.61 x C1.5 + 0.78 x C2 + 1.83 x C4 (for four time points, r(2) = 0.853). When these equations were tested in the validation group, there were no significant differences in prediction errors. Conclusion: An LSS using time points at 1.5, 2, and 4 hours or 0.5, 1.5, 2, and 4 hours provides the most accurate and reliable estimation of the MPA AUC0-12h in Chinese adult renal recipients treated concomitantly with EC-MPS and CsA during the early post-transplant phase.
引用
收藏
页码:138 / 146
页数:9
相关论文
共 35 条
[1]   Limited Sampling Strategies for Predicting Area Under the Concentration-Time Curve of Mycophenolic Acid in Islet Transplant Recipients [J].
Al-Khatib, Mai ;
Shapiro, R. Jean ;
Partovi, Nilufar ;
Ting, Lillian S. L. ;
Levine, Marc ;
Ensom, Mary H. H. .
ANNALS OF PHARMACOTHERAPY, 2010, 44 (01) :19-27
[2]   Validation of Limited Sampling Strategy for Estimation of Mycophenolic Acid Exposure During the First Year After Heart Transplantation [J].
Baraldo, M. ;
Cojutti, P. G. ;
Isola, M. ;
Feruglio, M. T. ;
Tursi, V. ;
Livi, U. ;
Furlanut, M. .
TRANSPLANTATION PROCEEDINGS, 2009, 41 (10) :4277-4284
[3]   Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies [J].
Bunnapradist, Suphamai ;
Ambuehl, Patrice M. .
CLINICAL TRANSPLANTATION, 2008, 22 (06) :815-821
[4]   Evalutation of mycophenolic acid systemic exposure by limited sampling strategy in kidney transplant recipients receiving enteric-coated mycophenolate sodium (EC-MPS) and cyclosporine [J].
Capone, Domenico ;
Tarantino, Giovanni ;
Kadilli, Irket ;
Polichetti, Giuliano ;
Basile, Vincenzo ;
Federico, Stefano ;
Sabbatini, Massimo .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (09) :3019-3025
[5]   Models for the Prediction of Mycophenolic Acid Area Under the Curve Using a Limited-Sampling Strategy and an Enzyme Multiplied Immunoassay Technique in Chinese Patients Undergoing Liver Transplantation [J].
Chen, Hao ;
Gu, Zhidong ;
Chen, Bing ;
Mao, Huarong ;
Zhang, Weixia ;
Fan, Qishi .
CLINICAL THERAPEUTICS, 2008, 30 (12) :2387-2401
[6]   Enteric-coated mycophenolate sodium immunosuppression in renal transplant patients: efficacy and dosing [J].
Cooper, Matthew ;
Salvadori, Maurizio ;
Budde, Klemens ;
Oppenheimer, Frederic ;
Sollinger, Hans ;
Zeier, Martin .
TRANSPLANTATION REVIEWS, 2012, 26 (04) :233-240
[7]   A Possible Simplification for the Estimation of Area Under the Curve (AUC0-12) of Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients Receiving Tacrolimus [J].
Fleming, Denise H. ;
Mathew, Binu S. ;
Prasanna, Samuel ;
Annapandian, Vellaichamy M. ;
John, George T. .
THERAPEUTIC DRUG MONITORING, 2011, 33 (02) :165-170
[8]   Tolerance of Enteric-Coated Mycophenolate Sodium in Combination With Calcineurin Inhibitor in Kidney Transplant Recipients: Polish Experience [J].
Gozdowska, J. ;
Urbanowicz, A. L. ;
Galazka, Z. ;
Chmura, A. ;
Durlik, M. .
TRANSPLANTATION PROCEEDINGS, 2011, 43 (08) :2946-2949
[9]   Bioequivalence of enteric-coated mycophenolate sodium and mycophenolate mofetil: A meta-analysis of three studies in stable renal transplant recipients [J].
Johnston, Atholl ;
He, Xiang ;
Holt, David W. .
TRANSPLANTATION, 2006, 82 (11) :1413-1418
[10]   A multicenter, randomized trial of increased mycophenolic acid dose using enteric-coated mycophenolate sodium with reduced tacrolimus exposure in maintenance kidney transplant recipients [J].
Kamar, Nassim ;
Rostaing, Lionel ;
Cassuto, Elisabeth ;
Villemain, Florence ;
Moal, Marie-Christine ;
Ladriere, Marc ;
Barrou, Benoit ;
Ducloux, Didier ;
Chaouche, Kamel ;
Quere, Stephane ;
Di Giambattista, Fabienne ;
Berthoux, Francois .
CLINICAL NEPHROLOGY, 2012, 77 (02) :126-136